[Interferon-beta in multiple sclerosis--who is going to be treated?].
Aarli
J A
JA
D000276:Adjuvants, Immunologic / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D005062:European Union; D006801:Humans; D016899:Interferon-beta / Q000191:economics* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000628:therapy*; D018579:Patient Selection
D000276:Adjuvants, Immunologic; D016899:Interferon-beta